UCLA's Electric Field-Induced Release and Measurement (EFIRM) system could offer the early detection of cancers and other diseases through a droplet-size saliva sample.

The organization noted that US senators have introduced a bill to accelerate Medicare coverage for breakthrough devices.

The MMR IHC Panel PharmaDx (Dako Omnis) is used to identify loss of function in mismatch repair proteins and inform the treatment of colorectal cancer patients.

Ospri specializes in PCR-based infectious disease detection and is financed by up to $30 million of strategic funding from Catalio Capital Management.

Last week, readers were most interested in a story about WHO's update to its operational handbook for diagnosing tuberculosis.

TBI is a potential new application area for the 8-year-old company, while it continues to commercialize its stroke triage ...

The submission releases $1.3 million in US funding support from the Biomedical Advanced Research and Development Authority (BARDA), the firm said.

The test is now authorized for use with anterior nasal swab samples in addition to the previously authorized throat and nasopharyngeal samples.

The technology can more effectively test for antibiotic susceptibility in heteroresistant bacterial populations than existing approaches.

The firm's goal for its SeekIt platform is to combine the accessibility of antibody and antigen testing and the accuracy of PCR for use in low-resource settings.

The firm said that it will use the money for working capital and general corporate purposes, and the raise follows a $3.25 million public offering that closed in May.